Economic evaluation of adalimumab versus etanercept for psoriatic arthritis in a Brazilian real-world model.

Background: TNF inhibitors are costly drugs supplied generally on health systems or private insurances. Performance analysis is essential to verify the results achieved by health technologies in th...